Pasquale Mitidieri - Sintetica Global Division

Can the respect be the key of the global growth in the pharmaceutical industry?

Sintetica Global Division is the international Division of Sintetica delivering injectable anaesthetics and analgesics to patients worldwide, through innovative science and excellence in development, production and marketing. Pasquale Mitidieri, Global Markets Corporate Director, tells us more about Global Division following their Awards as Growth Company Division of the year 2017 - Switzerland.

Established 1921 in Switzerland, Sintetica have sites based in Switzerland, Germany, Austria, Italy and United Kingdom, with the headquarters in Mendrisio, Switzerland. With 230 people employed in Europe with an average of 41-year coming from 25 different countries in the world. Sintetica’s focus is primarily on local anaesthesia and pain relief.

“Local anaesthesia and pain relief are two in which we have been the market leader for many years in Switzerland. Moreover, we are also seeking to develop a position in the growing field of neuromodulation” as Pasquale explains. In 2011, we established the global division, which was  the first international corporate structure. The global division was tasked with pursuing international growth under two distinct models, being a B2B licensing strategy and somewhat later a B2C strategy in select markets.

“Under the B2B model, we sought to license out our top brands to partners with whom we shared values. Foremost among these values is that people and relationships, including business relationships, come first, and thus Sintetica seeks to build business by finding partners with whom we can share our values. As such, all our partners must meet strict ethical criteria and share our innovation driven ‘quality without compromise’ value proposition. This was the most critical and difficult challenge we have faced since beginning our internationalization efforts, however I am proud to say that we have been very successful”

Today, we have submitted more than 300 product registrations in over 100 different countries via the network of partners we have built over the last five years. The first phase of expansion covered North, Central and South America, South East Asia, and the Pacific. Many of these registrations have yet to come through, but so far we have seen strong growth in the US, and some good returns in the Pacific. YOY growth is largely exceeding 50%, consolidating the impressive growth stream of the last years.

“We are fully committed to innovate therapies and drugs in local anaesthesia, pain management and neuromodulation. As such, we move forward with passion and competence in the full respect of people and the environment. All our efforts and resources are focused to become leader in these fields by developing novel medicine and better treatment options for physicians and patients worldwide.

“To achieve this leadership by innovation in the context of global growth, we consider strategic partnering and business development the key factors”.

Global division is therefore focusing on high speed robust partner selection and affiliation in every country of the world. It is determined to offer a dynamic portfolio of selected branded medicines, developed to answer unmet clinical needs, to build sustainable and long lasting alliances

“We have built an agile and multicultural high-performing Division to support the rapid global expansion. Global Division has two sites, one based in the HQs of  Mendrisio -Switzerland and the second in Como-Italy, from where all partners world-wide are managed.”

A novel structure of alliance managers is under final definition to cover the entire globe and ensure high level proximity support to our business partners to reinforce even more the long lasting fruitful cooperation model.

Recently, the Global Division found success in ACQ5 Global Awards 2017 as Growth Company Division of the Year Switzerland.

“It’s an incredible joy first and it represents a tangible reward to the huge efforts and strong ambition of all my team to move from a small Swiss excellence to a leading global company. This award makes me, my team  and all 230 employees of Sintetica proud and honored of the work done. At the basis of this amazing international success are our values and principles” Pasquale says.

When discussing what differentiates Sintetica Global Division from competitors, marking them out as the best possible option for their partners, Pasquale reflects on how the culture of Sintetica and all the strategic choices are firmly based on respect.

“Respect is the core value of the company and it permeates across every employee. The concept of respect is divided into three well-defined directions. It is expressed in relation to its employees, enhancing the different characteristics of each one. Whether for work or as an individual, through activities which create a pleasant environment in which to work and express themselves.

This same concept is also expressed towards the patients using Sintetica drugs worldwide, providing them with the highest quality products and investing in innovation to imagine the best care solutions for the future. Consequently, it materializes towards its global partners, showing them loyalty, absolute ethics and both operational and development support of advanced go to market strategies.

The convergence of these three well-defined areas make up the Sintetica Global Division  Value Proposition. It is a distinctive and strategic element of its own identity in the wide world panorama of the pharmaceutical industry.

Therefore, Sintetica does not only export drugs of the highest quality throughout the world, but also the complex of their own values.

The latter, shared by its network of global business partners, gives the Global Division unique characteristics in their approach to international markets and profound value in the go to market philosophy.

The culture of total respect and the focus to the individual person shall be considered as our fundamental heritage. The people are the real stars of our business and the biggest resource we count on to grow and develop the company.

At Sintetica, we seriously take the obligation to meet the highest standards of business ethics and integrity, and make meeting those standards the responsibility of all our employees. That is why, when hiring new employees, we look for ‘smart’ people who share our thirst for diversity, our respect for traditions and our aim to be a global leading company.

Visit: Sintetica Global Division